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Abstract 
Protein synthesis and secretion is a vital process to maintain cell function. As it demands 
numerous building blocks, cofactors and chaperones generated from metabolism and 
translation, the process is intertwined with metabolic and regulatory networks. To obtain an 
overall understanding of the protein synthesis and secretory system, multi-omics data are 
coupled with mathematical modeling to systematically quantify cellular resource reallocation 
in response to recombinant protein production and/or nutrient starvation. 
In this thesis, we mainly use two recombinant proteins, α-amylase and insulin precursor, as 
model proteins to study the protein synthesis and secretion process in a model organism 
Saccharomyces cerevisiae. We find that the central metabolism is reprogrammed at a large 
scale to relieve the oxidative stress caused by recombinant protein production, and the 
activation of Gcn2p-mediated signaling pathway plays a crucial role in reshaping metabolism. 
As protein folding is often considered the flux controlling step in protein synthesis and 
secretion, we further identify two routes of the protein folding pathway to improve protein 
production, namely through improved folding capacity and increased folding precision, 
respectively. Additionally, protein translation is the initial step of protein synthesis. We find 
that cells maintain large and unequally distributed reserves in translational capacity by 
stepwise reducing nitrogen availability. Moreover, we also construct a proteome-constrained 
genome-scale protein secretory model for S. cerevisiae (pcSecYeast) to perform secretory 
simulations and provide genomic targets for cell engineering. Our findings elucidate the 
global responses to various perturbations on protein synthesis and secretion and provide 
valuable novel insights that can be leveraged for improving recombinant protein production.  
 
Key words: protein synthesis, protein secretion, multi-omics analysis, genome-scale 
modeling, recombinant protein production 
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I don’t know anything, but I do know that  
everything is interesting if you go into it deeply enough. 
 









1.1 Saccharomyces cerevisiae 
The budding yeast Saccharomyces cerevisiae, which has been used for alcoholic 
fermentation for thousands of years (1, 2), is one of the most popular eukaryal organisms for 
studies of cell systems and production of various chemicals and recombinant proteins (3–8). 
The popularity benefits by many properties S. cerevisiae possesses, including i) its complex 
cellular structure contributes to studies of eukaryal molecular mechanisms; ii) high growth 
rate compared to other eukaryal organisms; iii) much information available about this 
organism through high-throughput studies, databases, sequenced genomes and extensive 
toolbox for molecular modification.  
1.2 Protein synthesis and secretion 
The central dogma of molecular biology states the flow of genetic information within a 
biological system. The transcription and translation processes initiate the protein synthesis 
process in cells. mRNA guides the assembly of free amino acids to synthesize polypeptide in 
ribosome with the assistance from tRNA. Next, the nascent polypeptide needs to be processed 
in the endoplasmic reticulum (ER) and the Golgi to form native protein structure, with help 
of the protein secretory pathway.  
Protein secretion is defined as the process of maturation of proteins destined for secretion, 
for the plasma membrane, the organelles or the extracellular space. In the 1960s, along with 
the development of electron microscopy, George Palade established the protein secretory 
pathway and its connection to the biogenesis of organelles (9). The protein secretory pathway 
in eukaryal cells is an elaborate machinery that consists of a number of independent 
organelles that work together efficiently to secret proteins to different destinations (10–13). 
Each organelle provides a specialized environment that facilitates the various stages in 
protein biogenesis, modification, folding and sorting. In yeast this pathway involves more 
than 160 proteins that are responsible for different post-translation processes (14). Most of 





The secretory pathway initiates from translocation of newly synthesized polypeptide through 
ER membrane. The translocation process can occur either co-translationally where translation 
and translocation are directly coupled, or post-translationally depending on the 
hydrophobicity and amino acid composition of the already fully translated signal peptide (15, 
16). In this process, the Sec61 complex is a commonly used channel for protein import into 
the ER.  
Protein glycosylation 
Since the majority of all secreted proteins are glycoproteins, the N-glycosylation is one of the 
most prevalent post-translational modifications in the ER. The N-linked oligosaccharides 
play an essential role in the protein folding quality control system. In the beginning, an 
oligosaccharide precursor Glc3Man9GlcNAc2 is assembled on the asparagine residue of the 
N-glycosylation recognition sequence of the nascent polypeptide during translocation (17), 
assisted by the ER-resident oligosaccharyltransferase. Additionally, at the hydroxyl groups 
of serine and threonine there will be O-glycosylation modification (18), which is catalyzed 
by protein O-mannosyltransferase. 
The protein folding quality control system 
The term ‘quality control’ describes the process of conformation-dependent molecular 
sorting of newly synthesized proteins in the ER (19). During the protein folding process, 
besides correctly folded proteins, there is also a fraction of misfolded and incompletely 
assembled proteins. 
In yeast, the secretory pathway is responsible for the modification and maturation of more 
than 550 proteins which are vital to maintain cell function. High-fidelity protein folding is a 
crucial step in the secretory pathway. Misfolded proteins, which can be caused by protein 
overproduction, externally applied stresses such as heat or oxidative stress, or genetic factors 
such as genetic mutations, transcription errors, or translation errors, are handled by the quality 
control system to be either refolded or delivered to the proteasome for degradation through 
ER-associated degradation (ERAD) pathway (20–22). Without proper handling by this 
quality control system, accumulation of misfolded proteins can be toxic to the cell. In humans, 
such accumulation can cause a number of severe diseases, such as Alzheimer’s disease, 
Parkinson’s disease, and type II diabetes (23). As a model eukaryal organism, the yeast S. 
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cerevisiae is a good model to study the secretory pathway and unravel the mechanisms related 
to these diseases (24). 
Unfolded protein response 
The accumulation of misfolded proteins results in ER stress that is handled by the unfolded 
protein response (UPR). Activation of the UPR results in transcriptional change of a large 
number of genes, which relates to around 400 genes in yeast (25). A result of this regulation 
is upregulation of chaperones and foldases as well as ERAD (26–28). Based on studies of the 
UPR many targets for improving protein secretion have been identified and implemented (7), 
and it is generally believed that any factor that reduces ER stress and its downstream damage 
caused by recombinant protein production results in improved secretion of the produced 
protein, and it is therefore important to engineer the secretory pathway to have the right 
capacity to process the protein of interest. 
Post ER processing 
The correctly folded proteins are transported into the Golgi for further processing. The coat 
protein complex II (COPII)-coated vesicles mediate the trafficking from the ER to the Golgi 
(29). In the Golgi, proteins are further maturated, e.g. hyper-mannosylation. After processing, 
proteins are sorted to different destinations, such as endosome, vacuole, plasma membrane 
or extracellular space, depending on their properties. Noteworthy, retrograde transport to the 
ER is also occurred to return cargo adaptor proteins, membrane components and escaped ER 
resident proteins, which is mediated by the coat protein complex I (COPI) (30, 31). 
1.3 The approaches in systems biology 
With the development of genomics, omics analysis and detailed mathematical models in the 
field of systems biology, it has become possible to perform very detailed phenotypic 
characterization of cells and use these for guiding metabolic engineering (4, 32). There are 
two different approaches to systems biology: in top-down systems biology, different types of 
high-throughput generated data, often referred to as omics data, are analyzed in an integrative 
approach, and in bottom-up systems biology, detailed models for specific processes, for 
example, enzymatic reactions, are assembled into a model describing the system being 
studied. The two approaches are complementary; top-down systems biology is useful for 
mapping cellular functions at the genome scale, whereas bottom-up systems biology enables 




Integrative analysis of omics data 
The availability of high-throughput experimental techniques, often referred to as omics 
techniques, has allowed a more in-depth study of cell systems. In particular, it has become 
possible to begin to address the general question of how cellular resources are allocated 
through integrative analysis of transcriptome, proteome, phosphoproteome, metabolome and 
fluxome. Integrative analysis of omics data usually uses biological networks to make it 
possible to identify parts of large networks that are coregulated (33). In this context, 
metabolic networks are therefore well suited because they are reconstructed using detailed 
biochemical information (34). Other biological networks, including gene ontology (GO) 
annotations that also reveal connections between genes, can also be used to identify gene-
enrichment groups or reporter features (34, 35), for example, reporter metabolites or reporter 
transcription factors. 
In this thesis, we study the cell systems through integrative study of transcriptome, proteome, 
phosphoproteome and exo-metabolome, and the analysis of GO bioprocess enrichment 
provides much useful information. 
Mathematical modeling 
For describing metabolism, mathematical models can be divided into two groups: kinetic 
models and stoichiometric models. In kinetic models, reaction rates are modeled as a function 
of metabolite concentrations and metabolite concentrations are modeled as a function of time 
(36). The model construction needs input of plenty of parameters, making the typical size of 
the model in a small scale (<100 metabolites). In stoichiometric models, a pseudo-steady 
state is assumed, and therefore, metabolite concentrations are not modeled and reaction rates 
are inferred by imposing steady-state mass balances on each metabolite (37), which makes 
stoichiometric models easier to be constructed in a large scale, even in the genome scale. 
In this thesis, we only focus on stoichiometric models. The genome-scale metabolic model 
(GEM) in yeast (Yeast8) (38) is used to simulate most flux distribution and enzyme usage in 
cells. In addition, we also construct a proteome-constrained secretory model (pcSecYeast) 
based on Yeast8, to show the particular molecular mechanisms in the secretory pathway. 
1.4 Recombinant protein production 
The production of recombinant proteins by microorganisms or cell cultures, including 
biopharmaceuticals and industrial enzymes, is a growing multibillion-dollar industry (39). 
Among these recombinant proteins, about 20% are being produced by S. cerevisiae (40, 41). 
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The advantages of using the yeast S. cerevisiae as a cell factory for the production of 
recombinant proteins are that the proteins can be secreted to the extracellular medium and 
this facilitates subsequent purification, and in many cases yeast can perform proper post-
translational modifications of the proteins, including proteolytic processing of signal peptides, 
disulfide bond formation, subunit assembly, acylation and glycosylation.  
In this thesis, we study the synthesis and secretion of two model recombinant proteins, insulin 
precursor (IP) and α-amylase. IP is a single chain peptide, containing 53 amino acid residues. 
There are three disulfide bonds and no N-glycosylation site in its native structure. α-Amylase 
contains 478 amino acid residues. There are three domains, four disulfide bonds and one N-
glycosylation site in its native structure. Investigation of these two proteins, with distinct 
molecular size, post-translational modifications and three-dimensional structures, makes it 
possible to obtain a universal understanding of the protein synthesis and secretion process. 
1.5 Chemostat culture 
Chemostat culture is one kind of typical modes of continuous cultivation. In chemostat, the 
medium is designed to ensure that there is a single limiting substrate, which allows for 
controlled variation in the specific growth rate of the biomass (42). For S. cerevisiae 
fermentation on minimal mineral medium, glucose is usually the limiting substrate in carbon-
limited chemostat culture and (NH4)2SO4 is usually the limiting substrate in nitrogen-limited 
chemostat culture. Since in a steady-state continuous bioreactor, the specific growth rate 
equals the dilution rate, the cells can be cultivated at different specific growth rates through 
control of dilution rate (or feed flow rate), which allows for precise experimental 
determination of the specific rates and is attractive for physiological studies.  
However, there is an upper threshold of dilution rate. Based on the Monod model, the mass 





Here 𝐷 is referred to as the dilution rate, 𝜇𝑚𝑎𝑥 as the maximum specific growth rate of the 
cell, 𝑐𝑠 as the concentration of the limited substrate, and 𝐾𝑠 as a specific substrate-related 
parameter. The value of 𝐾𝑠 equals the substrate concentration at which the specific growth 
rate is 0.5 𝜇𝑚𝑎𝑥. Since for a specific cell, the 𝜇𝑚𝑎𝑥 and 𝐾𝑠 are constant, it is easier to know 
that 𝐷 and 𝑐𝑠 keep positive correlation, and when 𝑐𝑠 increase to the substrate concentration 
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in the feed 𝑐𝑠
𝑓
, the dilution rate attains its maximum value, which is called the critical dilution 
rate: 







When the dilution rate becomes equal to or larger than 𝐷𝑐𝑟𝑖𝑡, the biomass is washed out of 
the bioreactor. A commonly used empirical value of 𝐷𝑐𝑟𝑖𝑡 for S. cerevisiae is 0.8-fold 𝜇𝑚𝑎𝑥. 
In addition to the advantages of precise control of specific growth rate and collection of 
physiological data at the steady state, chemostat can also be used to study dynamic conditions. 
For example, the substrate concentration can be suddenly changed by adding a pulse of the 
limiting substrate to the bioreactor or the temperature can be changed by adjustment of the 
heating system, and the cellular responses to the environmental changes can be studied.  
As mentioned above, chemostat culture can be used to avoid bias caused by differences in 
the growth rates of different strains and delays in protein synthesis, this mode is generally 
performed to study the physiological differences between different strains. In addition, for 
industrial application, although the product concentration in chemostat is often lower than 
the titer in fed-batch culture, the productivity could be high because of the high efficiency of 
continuous fermentation. It is reported that chemostat culture has been used for recombinant 
protein production in an industrial setting (43). 
In this thesis, all omics data are collected from cells grown in steady-state chemostat cultures.  
1.6 Aims and significance 
In this thesis, we study the protein synthesis and secretion process in S. cerevisiae through 
combination of integrative analysis of multi-omics data and mathematical modeling.  
Systematic characterization of yeast strains with recombinant protein production is a feasible 
approach to comprehensively understand the protein synthesis and secretion process. Firstly, 
we performed orthogonal experiments to evaluate strains producing proteins of different 
complexities, and at different yields, compared with the reference strain (from zero to one) 
(Paper I). We found that recombinant protein production remodeled the central carbon 
metabolism at a large scale, including decreased fermentation and respiration, enhanced 
glycolysis and tricarboxylic acid cycle (TCA cycle) to supply more cytosolic nicotinamide 
adenine dinucleotidephosphate (NADPH) and precursors for amino acids biosynthesis, and 
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increased glycerol production to maintain cellular redox potential. Finally, by analyzing 
phosphoproteomic abundance, we demonstrated a key role of Gcn2p-mediated signaling 
pathway on reshaping metabolism. Next, we investigated the rate-limiting steps in the 
secretory pathway for improving recombinant protein production, through characterization 
of evolved strains with high recombinant protein productivity, compared with the original 
strain (from one to hundreds) (Paper II). We identified different routes of the protein folding 
pathway to improve protein production, namely through improved folding capacity and 
increased folding precision, respectively. We further found that the regulation of N-glycans 
played an important role in the folding precision control, and overexpression of the 
glucosidase Cwh41p can significantly improve the protein production. 
Protein translation is the initial step of protein synthesis and secretion. As nitrogen is an 
important component of nucleotide and amino acid, herein we investigated the translation 
propensity through examining transcriptome, proteome and ribosomal protein abundance of 
yeast strains with different nitrogen accessibility (Paper III). We found that yeast growing 
in typical laboratory conditions maintains an overall 50% reserve proteome, 75% reserve 
transcriptome, and 50% reserve translational capacity, and ribosome reserves contained up 
to 30% sub-stoichiometric ribosomal proteins, with activation of reserve translational 
capacity associated with selective upregulation of 17 ribosomal proteins. We also identified 
that a major part of the translation capacity reserves is preferentially maintained for metabolic 
processes, highlighting the importance of a robust metabolism for cell growth and survival.  
Development of a secretory pathway-contained metabolic model contributes to 
comprehensive understanding of the process. In the final part of the thesis, I introduce our 
work on the construction of pcSecYeast (Paper IV). We added detailed reactions related to 
the secretory pathway, including translocation, glycosylation, folding and degradation, into 
Yeast8 to construct the model. We simulated the effects of protein misfolding on cell growth 
and the recombinant protein production process. We further predicted genomic targets for 
cell engineering to improve recombinant protein production with high accuracy. 
The studies in this thesis also demonstrate that how integrative analysis of omics data and 
mathematical modeling can be leveraged to provide valuable novel insights for systems 







2. The protein secretory pathway 
2.1 The link between protein secretory pathway and cellular central metabolism 
As mentioned previously, in this section, the original strain Qc, which carries an empty 
plasmid, was used as the reference strain, and four strains AIP, AIC, AAP and AAC, which 
carry a plasmid with recombinant protein production cassette but with different promoters 
(TEF1p or TPI1p) or producing different proteins (IP or α-amylase) were studied. Therefore, 
the genomes of all strains used in this section only are different on the promoters controlling 
the expression of recombinant protein production (Fig. 2-1), which helps eliminate the 
differences between strains caused by genome mutation or strain engineering. The strains 
were grown under chemostat culture with a specific growth rate of 0.2/h to further eliminate 
the differences on growth rate. We examined physiological parameters, proteome, 
phosphoproteome, transcriptome and intracellular amino acid concentrations of these five 
strains to elucidate the global cellular responses to recombinant protein production. 
 
Figure 2-1. Strains used in Paper I. IP, insulin precursor; Amylase, α-amylase. 
In chemostat cultures, the TPI1 promoter was found to be superior over the TEF1 promoter 
for production of both IP and α-amylase (Fig. 2-2a), which is in line with previous results in 
batch cultures (44). The protein production strains exhibited decreased ethanol production 
(Fig. 2-2b) and increased glycerol production (Fig. 2-2c) compared to the reference strain Qc, 
with larger differences in high yield strains (AIC and AAC), while all five strains exhibited 
comparable glucose uptake yields (Fig. 2-2d), biomass (Fig. 2-2e) and acetate production 
yields (Fig. 2-2f). The decreased ethanol yield indicates reduced fermentation and potentially 
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enhanced TCA cycle in the protein production strains. The increased glycerol yield suggests 
the importance of redox capacity for protein production, as the essential role of glycerol 
production in the maintenance of the redox potential (45). Furthermore, of the 14 amino acids 
supplemented in the media, several were taken up at higher rates by the protein production 
strains, including methionine, phenylalanine, tyrosine, tryptophan, leucine and threonine (Fig. 
2-2g). Uptake of methionine contributes to maintenance of redox balancing, as biosynthesis 
of one molecule of methionine in vivo requires three molecules of NADPH (46). In addition, 
the biosynthesis of three aromatic amino acids, phenylalanine, tyrosine and tryptophan, as 
well as leucine, demands more energy than others (47), indicating increased uptake of amino 
acids is driven by an economical strategy. All other amino acids showed same uptake rates 
between the strains. 
 
Figure 2-2. Overview of physiological parameters between strains. a Recombinant protein yield 
for each relevant strain. Insulin precursor for AIP and AIC; α-amylase for AAP and AAC. (b and c) 
Ethanol and glycerol yield for each strain. d Glucose uptake for each strain. e Final biomass for each 
strain. f Acetate yield for each strain. g Changes of uptake yield of glycine, methionine, phenylalanine 
and tyrosine in the protein production strains compared with Qc. Data shown are mean values ± 
standard errors of the means of biological triplicates. Statistical significance was determined by a two-
tailed Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.  
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We obtained absolute quantities of 3 944 proteins for each strain by proteome analysis. We 
further calculated the proteome allocation of 99 Yeast GO-Slim bioprocesses based on GO 
Slim Mapper annotations (48), and found that a number of processes were significantly re-
allocated in all protein production strains compared to the Qc strain (P < 0.05) (Fig. 2-3a). 
Several processes related to central carbon metabolism was remodeled, in either direction, in 
response to recombinant protein production: allocation to metabolic energy generation, 
carbohydrate metabolic process and monocarboxylic acid metabolic process were increased, 
but allocation to cellular respiration, mitochondrial translation and mitochondrion 
organization were decreased (Fig. 2-3a). Additionally, proteome allocation to several 
processes relevant to protein secretion were increased, including membrane fusion, organelle 
fusion and vacuole organization, while carbohydrate transport and ion transport were 
decreased. 
 
Figure 2-3. Proteome analysis reveals the changes of protein expression in response to 
recombinant protein production. a The differentially expressed biological processes (P < 0.05) at 
the proteome level in all protein production strains. All proteins were allocated to the 99 Yeast GO-
Slim biological processes. b Differentially expressed proteins (P < 0.05) relevant to ethanol 
production. c Differentially expressed proteins (P < 0.05) relevant to glycerol production. The 
expression levels of processes or proteins in Qc were used as the references.  
Ethanol and glycerol are the two primary by-products of central carbon metabolism in yeast. 
For ethanol metabolism, increased abundance of Ald4p, Ald6p, Acs1p and Acs2p in protein 
production strains suggested that more acetaldehyde was converted to Acetyl-CoA, which 
also induced the enhanced ethanol catabolism (Fig. 2-3b), in accord with the decreased 
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ethanol yield in protein production strains (Fig. 2-2b). Random sampling analysis also 
showed that the pyruvate to Acetyl-CoA reaction carried more flux in the protein production 
strains than Qc, while the pyruvate to acetaldehyde reaction carried less flux (Fig. 2-4). For 
glycerol metabolism, in line with the increased glycerol yield in the protein production strains 
(Fig. 2-2c), enzymes in its anabolic pathway were upregulated and enzymes in its catabolic 
pathway were downregulated (Fig. 2-3c).  
 
Figure 2-4. Carriable flux of the reaction pyruvate to Acyl-CoA or pyruvate to acetaldehyde in 
each strain. 
To further investigate central carbon metabolism, we compared the proteome allocation to 
glycolysis and the pentose phosphate pathway (PPP) between the protein production strains 
and Qc. In Qc, there was 7.9% of the proteome allocated to glycolysis, and to produce 
recombinant proteins, the allocation increased to 8.9% - 12.3% (Fig. 2-5a). On the other hand, 
the PPP allocation remained the same, at 0.6% in Qc, and 0.5% - 0.7% in the protein 




Figure 2-5. Proteome reallocation reveals the changes of central carbon metabolism in response 
to recombinant protein production. a Total proteome allocation to all enzymes in glycolysis was 
compared between protein production strains and Qc. b Total proteome allocation to all enzymes in 
the pentose phosphate pathway (PPP) was compared between protein production strains and Qc. c 
Changes of mitochondrial subgroups in the protein production strains compared with Qc at the 
proteome level. Data shown are mean values ± standard errors of the means of biological triplicates. 
Statistical significance was determined by a two-tailed Student’s t test. *, P < 0.05; **, P < 0.01; ***, 
P < 0.001. 
Proteomics analysis identified many downregulated processes present in the mitochondrion 
(Fig. 2-2a). To further unravel the mitochondrial changes in response to recombinant protein 
production, proteins located in the mitochondrion are allocated to different subgroups based 
on mitochondrial gene ontology (49) and significantly changed subgroups are shown in Fig. 
2-5c. Compared with Qc, most mitochondrial components had significantly decreased 
abundance in the protein production strains. In particular, the abundance of ATP synthases is 
significantly decreased in the protein production strains, indicating attenuated respiration. 
Correspondingly, flux balance analysis (FBA) results also showed that the relative ATP yield 
on biomass generated from respiration in these strains decreased compared with Qc (3.2%, 
8.6%, 8.2% and 1.1% decrease for AIP, AIC, AAP and AAC, respectively) (Fig. 2-6a). 
Conversely, the ATP yield from the TCA cycle increased to meet the cellular energy demand 
(43.9%, 88.2%, 47.7% and 20.2% increase for AIP, AIC, AAP and AAC, respectively) (Fig. 
2-6a). Moreover, while the abundance of enzymes in the TCA cycle decreased in the protein 
production strains, FBA results revealed that most enzymes exhibited a greater usage ratio 
and generally carried higher flux than the enzymes in Qc. Similar observations were made 
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for enzymes in amino acid biosynthesis as well. Further comparison of the fluxes showed 
that fluxes in respiration were comparable (Fig. 2-6b), but the fluxes with ATP generation in 
the TCA cycle increased a lot in the protein production strains (Fig. 2-6c). Hence, the total 
ATP yield either did not decrease (in AIP, AAP and AAC) or only slightly decreased (3.9% 
decreased in AIC). 
 
Figure 2-6. Changes in the energy generation pathways. a Relative ATP yield generated from 
respiration, glycolysis and TCA cycle between strains. b Carriable flux of ATP synthase in the 
mitochondrion. c Carriable flux of succinyl-CoA to succinate in the TCA cycle.  
The TCA cycle supplies the reducing agent nicotinamide adenine dinucleotide (NADH) for 
the respiratory chain resulting in ATP generation. Compared with Qc, the enhanced TCA 
cycle flux and decreased respiration in the protein production strains indicated an imbalance 
in NADH formation and consumption. Further investigation, however, showed that the 
enhanced TCA cycle generated more cytosolic NADPH and not mitochondrial NADH 
through oxidation of isocitrate to α-ketoglutarate (AKG). The oxidation of isocitrate to AKG 
in the mitochondrion can be catalyzed by Idh1p, Idh2p, or Idp1p, producing either NADH 
(Idh1p and Idh2p) or NADPH (Idp1p), and in the cytoplasm, this reaction is catalyzed by 
Idp2p only and is NADP-specific (50) (Fig. 2-7a). Proteome analysis revealed that with same 
total amount of these four enzymes, the fraction of Idp2p increased in the protein production 
strains (Fig. 2-7b). In line with this, random sampling analysis showed that the mitochondrial 
NAD-specific isocitrate dehydrogenative reaction carried comparable flux in each strain (Fig. 
2-7c), but the cytosolic NADP-specific reaction in protein production strains was able to 
carry 7.9-fold to 13.1-fold higher flux than in Qc (maximum carriable flux was 1.57, 1.10, 
1.32, 0.95 and 0.12 for AIP, AIC, AAP, AAC and Qc, respectively, with the unit of mmol 
gDCW-1 h-1) (Fig. 2-7d). At the same time, the flux carried by the mitochondrial NADP-
specific reaction was very low in each strain (Fig. 2-7e), indicating a low NADPH demand 
in the mitochondrion. The PPP is also a crucial pathway to generate cytosolic NADPH, but 
in the protein production strains, the two NADPH-generated reactions in the PPP carried low 
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and comparable fluxes, compared with Qc (Fig. 2-7f and g), in agreement with the result that 
a similar fraction of proteome was allocated to the PPP in each strain (Fig. 2-5b).  
 
Figure 2-7. More cytosolic NADPH is provided by oxidation of isocitrate to AKG. a Oxidation 
of isocitrate to AKG is under catalysis of four enzymes. b Proteome allocation to Idp2p and total four 
enzymes catalyzing the oxidation of isocitrate to AKG. c Carriable flux of isocitrate to AKG catalyzed 
by Idh1p and Idh2p. d Carriable flux of isocitrate to AKG catalyzed by Idp2p. e Carrible flux of 
isocitrate to AKG catalyzed by Idp1p in the TCA cycle. f Carriable flux of G6P to 6PGL in the PPP. 
g Carriable flux of D6PGC to Ru5P in the PPP. AKG, α-ketoglutarate. Carriable fluxes of relevant 
reactions with NADH or NADPH generation. G6P, glucose 6-phosphate; 6PGL, 6-
phosphogluconolactonase; D6PGC, 6-phosphogluconate; Ru5P, ribulose-5-phosphate. For panel b, 
data shown are mean values ± standard errors of the means of biological triplicates. Statistical 
significance was determined by a two-tailed Student’s t test. *, P < 0.05; **, P < 0.01.  
In phosphoproteomic analyses, we identified 836-1,533 phosphorylated sites that are 
differentially expressed, in any one of the protein production strains, compared to Qc (P < 
0.05) (Fig. 2-8a). Regarding the overlapped 140 phosphorylated sites which were 
significantly changed, the abundance of 25 sites was upregulated and the abundance of 110 
sites was downregulated in all protein production strains (Fig. 2-8b). The highly conserved 
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regulation of phosphorylation events (135 out of 140 sites) indicated the importance of these 
proteins on protein production.  
 
 
Figure 2-8. Overview of phosphoproteomics changes. a Overlaps of phosphorylation sites with 
significantly changed abundance (P < 0.05) compared with Qc between protein production strains. b 
Changes of phosphorylation abundance regarding the overlapped 140 protein sites.  
GO term enrichment analysis of these proteins revealed several processes relevant to 
translation, including regulation of translational initiation, mature ribosome assembly and 
translational initiation. At the protein level, there were 6 proteins related to translation, i.e. 
Fun12p, Gcd6p, Gcn2p, Gcd1p, Tif5p and Tif6p. The phosphorylated forms of these 6 
proteins were significantly decreased in the protein production strains compared with Qc (Fig. 
2-9a), but the abundance of these proteins did not show any differences (Fig. 2-9b), indicating 
the importance of protein phosphorylation as a regulatory mechanism of translation-related 
processes.  
 
Figure 2-9. Overview of phosphoproteomics and proteomics changes of proteins involved in 
translation process. a Changes of phosphorylation abundance in proteins relevant to translational 
regulation compared with Qc. b Changes of abundance at the protein level compared with Qc.  
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Of these 6 proteins, Gcn2p is an important protein kinase responsible for sensing starvation 
in a dynamic environment (51). Gcn2p is activated via dephosphorylation of Gcn2p-Ser-577 
in amino acids-deprived cells (52), which was observed in all protein production strains (Fig. 
2-9a). The activated Gcn2p is able to phosphorylate the α subunit of eukaryotic initiation 
factor 2 (eIF2α) and further reduce general protein biosynthesis but specifically induce the 
expression of Gcn4p and over 500 genes under its control (Fig. 2-10a), including many amino 
acid biosynthetic genes (53). Since amino acid starvation is known to be a common signal to 
activate the Gcn2p signaling pathway (54), we therefore examined the intracellular 
concentrations of 20 natural amino acids for each strain. Our results showed that, overall 
there were less free amino acids in the protein production strains than Qc, with particularly 
low concentrations of alanine, suggesting that alanine starvation is a likely signal inducing 
the activation of Gcn2p in this context (Fig. 2-10b). Additionally, methionine and aromatic 
amino acids showed very low concentration in all strains (Fig. 2-10b), which was in line with 
their higher biosynthetic costs (47). Amino acid starvation also induces the repression of the 
target of rapamycin complex 1 (TORC1) (55), which in turn leads to decreased 
phosphorylation of a large number of proteins (56). In the two high yield strains, there were 
14.9% (250 out of 1 676) proteins with decreased phosphorylation events, and given the scale 
to TORC1 targets, the fraction was 23.6% (13 out of 55) (Fig. 2-10c), indicating that TORC1 
was repressed in these strains. Furthermore, we found that all Gcn4p regulated genes (both 
upregulation and downregulation) were differentially expressed in all protein production 
strains compared to Qc (Fig. 2-10d), suggesting that Gcn4p was activated in response to 
protein production. 
In addition to Gcn2p-Ser-577, two phosphorylation sites on the complex eukaryotic initiation 
factor 2B (eIF2B), Gcd1p-Ser-296 and Gcd6p-Ser-449, also showed decreased 
phosphorylation. Since eIF2B activity is inhibited by phosphorylation of eIF2α and 
negatively regulates the expression of Gcn4p (Fig. 2-10a), it is likely that the 





Figure 2-10. Activation of kinase Gcn2p induced the activation of Gcn4p. a The Gcn2p signaling 
pathway activated by amino acid starvation. b Intracellular abundance of alanine, glutamate and 
methionine in all strains. Data shown are mean values ± standard errors of the means of biological 
triplicates. Statistical significance was determined by a two-tailed Student’s t test. *, P < 0.05; **, P 
< 0.01; ***, P < 0.001. c Fraction of dephosphorylated proteins in the high yield strains (AIC and 
AAC) compared with Qc, and the ratio of the number of these proteins to the number of TORC1-
repression induced dephosphorylated proteins. Binominal cumulative distribution function was used 
to calculate the P value. d Changes of expression level of gene sets regulated (upregulated or 
downregulated) by Gcn4p in the protein production strains. Qc was used as the reference. 
 
 
2.2 The rate-limiting steps inside the secretory pathway 
In section 2.1, I show the global reprogramming of central carbon metabolism in response to 
recombinant protein synthesis and secretion. To further unravel the mechanisms of the 
complicated protein secretory pathway, recombinant protein with more complex structure 
and modifications, and yeast strains with higher production yield, are more valuable to be 
studied. Herein we characterize the strain AAC, the high α-amylase yield strain in section 
2.1, and two evolved strains with higher α-amylase yields (Fig. 2-11), to explore the crucial 




Figure 2-11. Relationships among the α-Amylase production yeast strains used in Paper II. All 
three strains were grown in chemostat cultures operated at dilution rates of 0.1/h and 0.2/h.  
Previous work showed that a higher specific growth rate was coupled to higher recombinant 
protein production in chemostat cultures (57). In view of the maximum specific growth rates 
of these three strains (0.276/h, 0.329/h and 0.310/h for AAC, MH34 and B184, respectively) 
(58), we cultured the strains at dilution rates of 0.1/h and 0.2/h. Compared with the reference 
strain AAC, we found that the α-amylase productivity of MH34 and B184 was significantly 
improved at both dilution rates (Fig. 2-12a), which is in agreement with the results obtained 
for batch cultures (58). However, in batch culture, B184 produced α-amylase with 1.29-fold 
increase of yield and 47% increase of productivity compared with MH34. In contrast, in 
chemostat cultures, we found that the yield or the productivity of B184 was only 14% greater 
than that of MH34 at 0.2/h, and even 22% lower at 0.1/h, indicating the different mechanisms 
for improved protein production between MH34 and B184. To compare the fraction of 
misfolded α-amylase between three strains, we also measured the intracellular α-amylase 
abundance and activity (Fig. 2-12b and c). Compared with B184, we found that in MH34 the 
abundance was greater but the activity was lower, which means a higher fraction of misfolded 
α-amylase in MH34 than in B184.  
The absolute quantitative proteome for AAC, MH34 and B184 grown in steady-state 
chemostat cultures at dilution rates 0.1/h and 0.2/h were analyzed. Proteins were annotated 
based on the Yeast GO-slim bioprocess mapper (48), analyzed the changes of specific 
bioprocesses in the proteome and listed the processes changing significantly (P < 0.05) in 
MH34 or B184 revealed by proteome analysis (Fig. 2-13). Out of 99 Yeast GO-slim 
bioprocesses, only 18 processes were differentially expressed, with the scale of log2 fold 
change from -0.82 to 1.55. Clearly the proteome changes in a specific manner that precisely 
impacts bioprocesses related to protein production, including amino acid transport, vitamin 




Figure 2-12. α-Amylase production in steady state of chemostat culture. a α-Amylase 
productivity of strains in steady state of chemostat culture. b Relative intracellular α-amylase 
abundance of strains in chemostat culture. c Intracellular α-amylase yield of strains in chemostat 
culture. Data shown are mean values ± standard errors of the means of biological duplicates. 
 
 
Figure 2-13. The differentially expressed biological processes (P < 0.05) in MH34 and B184 
revealed by proteome allocation. All proteins were allocated to the 99 Yeast GO-slim biological 
processes. The proteome fraction (g/g) for each process was used. The expression levels of processes 
in AAC at 0.1/h and 0.2/h, respectively, were used as the reference. 
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Since energy metabolism is important for protein synthesis and secretion (59). We next 
investigated the abundance of proteins involved in carbohydrate transport and 
oligosaccharide metabolism, which were upregulated in the high α-amylase production 
strains (Fig. 2-13). The upregulated proteins mainly participate in glycogen metabolism (Fig. 
2-14), which links carbohydrate metabolism to protein glycosylation and folding via the 
production of uridine diphosphate glucose (UDP-glucose) (60). α-Amylase is a glycoprotein 
which carries one of N-glycans. And UDP-glucose is a critical precursor of N-glycans, the 
changes in composition of which act as a signal that guides the folding process for 
glycoproteins. For example, when the N-glycan changes from G3M9 (Glc3Man9GlcNAc2) to 
G1M9 (Glc1Man9GlcNAc2) the protein is better folded by relevant enzymes and chaperones, 
and when it changes from M8 (Man8GlcNAc2) to M7 (Man7GlcNAc2) there is increased 
targeting of the protein to ERAD for degradation (20). Hereby the upregulation in glycogen 
metabolism is able to offer more available sugars, which could be recruited by N-glycans and 
store more sugars that are trimmed from N-glycans, which could support the increased protein 
production in MH34 and B184. 
 
Figure 2-14. Differentially expressed proteins (P < 0.05) related to glycogen and trehalose 
metabolism. The expression levels in AAC at 0.1/h and 0.2/h were used as the reference accordingly.  
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Differ from glycogen metabolism, trehalose metabolism showed differences between MH34 
and B184. The proteins in trehalose metabolism were upregulated mainly in MH34, but not 
in B184 (Fig. 2-14). Previous studies had shown that trehalose exerts bidirectional effects on 
protein folding (61, 62). On the one hand, trehalose can help to prevent folded proteins from 
denaturing and misfolded proteins from aggregating. On the other hand, trehalose interferes 
with refolding of denatured proteins by relevant molecular chaperones. Therefore, the 
upregulation of the trehalose cycle in MH34 suggests a dynamic control of the trehalose 
concentration in the cell, which is line with the fact that there are more misfolded proteins in 
MH34 than in B184. To test this hypothesis, we calculated the energy used for protein 
synthesis and secretion based on a genome-scale metabolic model with enzyme constraints 
(Yeast8) (38). Energy used for protein production is a component of the non-growth 
associated maintenance energy (NGAM) in Yeast8, which we found to be always lower in 
B184 than in other strains (Fig. 2-15). Especially compared with MH34, due to their similar 
α-amylase productivity in chemostat, the lower NGAM in B184 indicated that B184 
expended less energy than MH34 to produce the same amount of correctly folded α-amylase, 
which was in line with the finding that the fraction of misfolded α-amylase was greater in 
MH34 than in B184. 
 
Figure 2-15. The non-growth associated maintenance energy (NGAM) in chemostat cultures as 
calculated with assistance of the Yeast8 model.  
The overall proteome allocation analysis revealed significant differences in protein synthesis 
associated processes in addition to energy metabolism (Fig. 2-13 and 2-14). We next focused 
specifically on the protein secretory pathway, which involves more than 160 proteins that are 
responsible for different post-translational processes in yeast. A previous yeast protein 
secretory model divided the secretory machinery into 16 subsystems (14). To reduce the 
complexity, we merged subsystems with similar functions and simplified the secretory 
pathway into 8 subsystems, including translocation, ER glycosylation, folding, ER 
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glycosylphosphatidylinositol (GPI) anchoring, ERAD, trafficking between ER and Golgi, 
Golgi processing and sorting.  
Proteome analysis revealed the differences in protein glycosylation and folding processes 
between strains. As a glycoprotein, the folding pathway is directed by the change of the 
composition of N-glycans (Fig. 2-16). Therefore, we further investigated the involved 
proteins in these strains to elucidate the specific contributors. 
 
 
Figure 2-16. N-glycan directed protein folding pathway. 
 
Within the ER glycosylation process, there were more downregulated proteins in MH34 than 
in B184 (Fig. 2-17). Among them, Alg11p and Ost1p, which regulated the synthesis of N-
glycan (20), are downregulated at both dilution rates in MH34, but not in B184. And 
correspondingly, within the folding process, the glucosidase Cwh41p, which catalyzes the 
first step in N-glycan trimming and initiates the folding process (Fig. 2-16), was upregulated 
at both dilution rates in B184, and only at 0.2/h in MH34. On the other hand, Pdi1p was the 
only protein in the folding pathway to be upregulated at both dilution rates in MH34 (Fig. 2-
17). This is in line with its role in disulfide bond formation during protein folding as well as 
in guiding misfolded proteins to ERAD (20). Previous studies already reported that 




Figure 2-17. Differentially expressed proteins (P<0.05) related to the ER glycosylation process 
and the folding pathway. The expression levels in AAC at 0.1/h and 0.2/h, respectively, were used 
as the reference. 
To validate if the regulation of synthesis and trimming of N-glycans could increase the protein 
yield and cause the differences between MH34 and B184, we studied the role of Cwh41p on 
protein production. At first, we tested different promoters for overexpression. We 
overexpressed CWH41 under the control of either a strong promoter or the CWH41 native 
protomer carried by a multi-copy plasmid in AAC. We also tested the overexpression of 
Rot2p, which catalyzes the second step in N-glycan trimming (Fig. 2-16). The α-amylase titer 
increased with overexpression of CWH41, particularly when expressed under its native 
promoter, reaching a 40% increase in α-amylase production (Fig. 2-18a). Interestingly, the 
final biomass was significantly increased in this strain as well, which was rarely observed in 
previous engineering studies (8, 58, 64). In general, the final biomass is most of the times 
lower in strains engineered to overproduce recombinant proteins, since increased protein 
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production overloads the folding burden of the cell, leading to accumulation of misfolded 
proteins and increased energy expenditure in response to cell stress (65). One example is the 
overexpression of PDI1, which increased α-amylase yield but decreased final biomass (8). 
Here the increase of both α-amylase production and final biomass suggests that CWH41 
overexpression improves protein production without accumulation of misfolded proteins. In 
other words, CWH41 overexpression might lead to more precise protein folding, consistent 
with the decreased fraction of misfolded α-amylase in B184. 
A previous study reported that the overexpression of PDI1 under the control of the TEF1 
promoter resulted in a higher α-amylase yield than overexpression using its native promoter 
(8). In case of CWH41 and ROT2, the native promoters led to better results (Fig. 2-18a). 
Therefore, here we performed single-copy combinatorial overexpression in AAC with the 
superior promoter for each gene to further evaluate the role of Cwh41p (Fig. 2-18b). The data 
showed that the overexpression of CWH41 itself did not increase the α-amylase yield in AAC, 
but the combinational overexpression of PDI1 and CWH41 did further increase the yield 
compared with the overexpression of PDI1 alone, which could indicate that the increase of 
folding precision is more important for strains with improved protein folding capacity. To 
further validate this, we engineered the strain MH34, which has an improved folding capacity 
compared with AAC. Both of the multi-copy overexpression via plasmid (Fig. 2-18c) and 
single-copy combinatorial overexpression (Fig. 2-18d) showed that CWH41 can increase the 
α-amylase yield. In details, the single-copy combinatorial overexpression revealed that 
CWH41 itself can help to increase the α-amylase yield by 27%, compared with the 43% 
increase in B184 at the same condition (Fig. 2-18d), which is in line with the observation that 
overexpression of CWH41 helped to further increase the yield in an AAC strain already 
overexpressing PDI1. For PDI1, the expression level was already upregulated in MH34 (Fig. 






Figure 2-18. Overexpression of CWH41 contributes to α-Amylase production. a Promoters 
evaluation for overexpression of CWH41 or ROT2 from plasmids. The plasmid pSPGM1 was used 
for the gene overexpression. b α-Amylase titer, biomass and α-amylase yield of engineered strains in 
the background of MH34. The plasmid pSPGM1 was used for the gene overexpression. c α-Amylase 
titer, biomass and α-amylase yield of engineered strains in the background of AAC. d α-Amylase titer, 
biomass and α-amylase yield of engineered strains in the background of MH34. Data shown are mean 
values ± standard errors of the means of biological triplicates. Statistical significance was determined 
by a two-tailed Student’s t test. *P < 0.05.  
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Proteome analysis suggested that Cwh41p and Pdi1p are two important proteins in this 
context. Herein we also studied the regulatory mechanisms of these two proteins based on 
their mRNA abundance, protein abundance and translation propensity (protein abundance / 
mRNA abundance, abbreviated to P/T) among three strains (Fig. 2-19). For Cwh41p, 
compared with AAC, at transcriptional level there was limited increase in the evolved strains 
(less than 5% increase in B184 at 0.1/h, and even decrease under other three conditions), and 
at the translational level the abundance significantly increased (over 100% increase in B184 
at both dilution rates). Thus, the increase of Cwh41p mainly depends on post-transcriptional 
regulation. And for Pdi1p, there was already significant increase at transcriptional level in 
the two evolved strains, but the different post-transcriptional regulation led to different 
protein abundance (over 50% increase of P/T value in MH34 at both dilutions, and decreased 
P/T value in B184). Thus, the regulation of Pdi1p needs both transcriptional and post-
transcriptional regulation. 
 
Figure 2-19. The mRNA abundance, protein abundance and translation propensity (protein 
abundance / mRNA abundance) of CWH41 or PDI1 of strains in chemostat cultures. a and b 
show the properties of CWH41 expression under 0.1/h and 0.2/h, respectively. c and d show the 







3. Translation – the initiation of protein synthesis 
The translation process translates mRNA to polypeptide in the organelle ribosome. A 
quantitative measurement of transcriptome, proteome and abundance of ribosomal proteins 
enables a more comprehensive understanding of the protein synthesis process. To further 
characterize the correlation between mRNA and protein, as carbon and nitrogen are two 
important elements in the composition of nucleotide and amino acid, the supplemented C/N 
ratio is changed by stepwise reducing the nitrogen content in the growth medium. 
The typical elemental composition of yeast dry biomass is ~49% carbon and 9% nitrogen by 
weight (66), which represents a C/N ratio of 5.4. In typical carbon-limited chemostat cultures, 
nitrogen is provided in excess with C/N ratio of 3-4 in the growth medium (67, 68). Reducing 
the nitrogen content in the growth medium to a C/N ratio of 50-115 leads to total protein and 
mRNA in the cell declining to 50% and 25% of the amount measured in C-limited cultures, 
respectively (Fig. 3-1). Further reducing nitrogen availability reduced the steady-state 
biomass, but did not further decrease the RNA and protein fraction, suggesting these levels 
to be the minimum required for cell growth at a constant dilution rate of 0.2/h (Fig. 3-1). 
Under these nitrogen-limited conditions therefore, we consider the transcriptome and 
proteome allocation of the cell to be fully economized.  
Cells maintain reserves in translational capacity, including but not limited to excess/inactive 
ribosomes (69–71). In our dataset, since the total protein-to-mRNA ratio was doubled under 
N-limitation (Fig. 3-1), this places the overall translational reserve at approximately 50% 
capacity in C-limited cultures; a conservative estimate, as this approximation neglects protein 
turnover. As both the transcriptome and proteome allocation for different cellular processes 
maintained a similar % of reserves, we next investigated whether this is true for cellular 





Figure 3-1. Total protein and mRNA content of the biomass under each culture condition. Bars 
are mean + standard deviation of biological duplicates. 
 
 
Figure 3-2. Reserves in translational capacity. a Gene-specific translation efficiency was calculated 
in all growth conditions. ***, P < 0.001, Student’s t test. b Genes were grouped based on the step of 
nitrogen reduction at which their translation efficiency was increased by log2 > 1. Data points reflect 
the median translation efficiency of each group, with the # of genes belonging to each group shown 
in parentheses. Horizontal dashed line indicates 2-fold increase from C-limited cultures.  
 
Using protein and mRNA abundances from this dataset, and by mining protein turnover data 
from Lahtvee et al (2017) (68), we calculated protein synthesis efficiency ksP (protein/mRNA 
h) for each protein. With step-wise reduction of nitrogen content in the growth media, ksP was 
globally increased (Fig. 3-2a), indicating that reserve translational capacities were placed into 
usage: a 2-fold increase in the ksP of a gene implicates a 50% reserve translational capacity 
for this gene under typical C-limited growth. To study this response, we further grouped 
genes based on the step of nitrogen reduction at which ksP was increased by >2-fold, which 
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splits a total of 3,361 genes into 4 groups of similar sizes (Fig. 3-2b). The step of ksP 
modulation correlated with the effect size: those genes with an increased ksP at C/N=30 (Fig. 
3-2b, group 1), were also the genes with the largest ksP increase at C/N=115. When nitrogen 
availability is at its lowest, at C/N=115, this group of genes has a median ksP increase of 5.6-
fold (Fig. 3-2b), implicating an 82% reserve translational capacity under typical C-limited 
growth. Remarkably, this group of genes were enriched exclusively in processes related to 
metabolism (Fig. 3-3, group 1). This is consistent with our observation that the abundance of 
enzymes within a given metabolic pathway have a higher propensity to be internally adjusted, 
while proteome and transcriptome allocation to the pathway as a whole remain constant. 
Taken together, these results show that the vast majority of cellular reserves are dedicated to 
metabolism, in line with the growing consensus that yeast have evolved complex regulatory 
mechanisms to control metabolic pathways.  
At the final step of nitrogen reduction in the growth medium, a total of 2,490/3,361 genes 
(74%) exhibited a >2-fold ksP increase, demonstrating >50% reserve in their translational 
capacities when growing in C-limited conditions (Fig. 3-2b). These genes were enriched for 
a variety of cellular processes (Fig. 3-3). The remaining 26% of genes showed little to no 
modulation of ksP and were enriched in translation/protein processing-related GO-slim terms 
(Fig. 3-3). This indicates that components of the translational machinery were themselves 
being translated at maximum capacity in C-limited cultures, and therefore the changes in the 
abundance of protein related to these processes are predominantly regulated at the transcript 
level. Finally, we observed no significant enrichment (pFisher > 0.01) in any of the 4 groups 
herein for essential genes (48), indicating that the unequal distribution of these reserves is not 





Figure 3-3. Reserves of translational capacity are preferentially used to translate metabolic 
proteins. Enrichment of GO-slim terms in each gene group as defined in Fig. 3-2b was analyzed by 
Fisher’s exact test. GO-slim terms with FDR-adjusted pFisher < 0.05 in at least one gene group are 
shown. 
The observation that cells preferentially maintain reserve translational capacities for some 
processes (metabolism) but not others (components of the translational machinery) is 
interesting, considering that functionally distinct sub-pools of mRNA are known to be 
translated by subsets of ribosomes with distinct ribosomal protein (RP) stoichiometry (72–
74). RP stoichiometry has also been shown to depend on the balance between the economics 
of protein production and cell growth (75). To investigate this further, we examined RP 
stoichiometry in our proteomics dataset for C-limited cultures, and found that of the 76/79 
RP subunits detected (from 94/117 non-identical RPs), their abundance spanned >2 orders of 
magnitude, even when their paralogs were summed. This large variation could not be 
accounted for by differences in RP degradation rate (68), molecular weight, order of assembly 
(76); or parameters of the MS such as the number of peptides detected or the coverage of 
each RP’s protein sequence. Interestingly, most deviations from mean RP abundance and 
rRNA abundance were sub-stoichiometric RPs, while few RPs were over-represented (Fig. 
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3-4a). This indicates that a substantial number of ribosomes in the cell likely contain a sub-
stoichiometric composition of RPs that are available.  
To validate this finding, we performed targeted quantitative proteomics for 26 RPs by TMT-
based MS, using 49 proteotypic peptides that were chemically synthesized at known 
quantities as standards. After tryptic digest and labeling with isotopic mass tags, the synthetic 
peptide standards and the pooled reference sample were multiplexed at 8 different ratios to 
ensure that MS intensity ratios cover the dynamic range of TMT (77). This analysis 
confirmed that iBAQ-based quantification is robust to the order of magnitude, for 23 out of 
26 (88%) RPs. We note here that, for a few RPs, the measured abundance of different peptides 
differed by >10-fold, e.g. for RPL30 and RPL37A, which could have arisen from partial 
degradation during sample preparation and handling. In all cases, the average of all peptides 
was taken as the abundance of the RP. This analysis further indicated that any post-
translational modifications on these peptides did not significantly interfere with the absolute 
quantification by MS, since the synthetic peptide standards are not modified. Thus, we 
confirmed that the abundance of RP subunits in a cell is markedly different from the typically 
assumed 1:1 stoichiometry. Out of the 76 RP subunits detected in our dataset, 54 (70%) were 
expressed in the order of 105 molecules/cell (mean = 3 x 105 molecules/cell), in line with 
classic estimates of ribosome content (78); while 22 (30%) RP subunits were sub-
stoichiometric by up to an order of magnitude. 
 
Figure 3-4. Ribosome reserves contain diverse sub-stoichiometric ribosomal proteins (RP). a 
RP:rRNA ratio for each RP was calculated in all growth conditions. **, P < 0.01; ***, P < 0.001, 
Student’s t tests. b Model of ribosome complex diversity and abundance. Each complex ribosome 
contains 54 “core” RP subunits expressed in the order of 105 molecules/cell, and samples a subset of 
22 RP subunits expressed at 104 molecules/cell. c The total number of ribosomes in the cell decreases, 
while diversity of ribosomes varies parabolically, with the number of RP subunits complexed.  
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From this data, a simple model of ribosome complex diversity and abundance emerges (Fig. 
3-4b and c). Each complexed ribosome likely contains the 54 “core” RP subunits that are 
expressed in the order of 105 molecules/cell, and a subset of the 22 RP subunits, expressed in 
the order of 104 molecules/cell (Fig. 3-4b). Thus, the total number of ribosomes that can be 
complexed with n RP subunits decreases with increasing n when n > 54 (Fig. 3-4c). The 
diversity of ribosome subunit composition varies parabolically with n, with peak diversity 
occurring with complexes of n = 64-65 RP subunits, where >106 combinations are 
theoretically possible (Fig. 3-4c). Notably, for complexes of n = 58 to n = 71, the number of 
possible RP subunit combinations exceeds the actual number of ribosomes that can be built 
with n RP subunits (Fig. 3-4c). This means that it is possible for these ribosomes to re-
assemble into completely new RP subunit compositions if needed, pointing to a dynamic pool 
of ribosome reserves that can quickly respond to changing growth environments by adjusting 
their RP subunit stoichiometries.  
 
 
Figure 3-5. Relative abundance of RP subunits in N-limited chemostats compared to C-limited 
chemostat. RP paralogs were summed and labeled with standard gene name.  
As nitrogen is reduced in the growth media, less RPs are detected at sub-stoichiometric levels 
to rRNA (Fig. 3-4a), with 17 RP subunits (22 RPs) being selectively upregulated by >2-fold 
(Fig. 3-5). This upregulated RP pool includes 3 RP subunits where one paralog of the paralog-
pair (RPL21B, RPL6A, and RPS7A) was upregulated, while the other (RPL21A, RPL6B, 
RPS7B) was not, indicative of a paralog-specific response to nitrogen reduction. Interestingly, 
not all RPs upregulated in the N-limited cultures were sub-stoichiometric in the control C-
limited culture, and vice versa, implicating multiple levels of control for RP subunit 
incorporation and ribosomal translation efficiency. Benchmarking the quality of this gene set 
is the inclusion of Asc1 (Fig. 3-5), a peripheral RP in the small subunit that is known to 
promote ribosomal activity. In particular, such activity is targeted towards highly translated 
mRNAs containing short ORFs (79), with Asc1p interacting with the pre-initiation complex 
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(80), the closed-loop complex (79), and RNA-binding proteins (RBPs), to tether mRNAs to 
the translational machinery (81, 82). These adjustments in ribosome composition (Fig. 3-5) 
may therefore be responsible, at least in part, for the global increase in ksp under nitrogen 
limitation (Fig. 3-2a), by helping sub-stoichiometric ribosome reserves engage with and 
translate mRNA, with a preference for those encoding metabolic enzymes (Fig. 3-3). Taken 
together, these observations suggest the intriguing possibility that RP stoichiometry can be 










4. Proteome-constrained secretory modeling 
The latest yeast genome-scale metabolic model (GEM) Yeast8 (38) represents a 
comprehensive computational resource for performing simulations of the metabolism in yeast, 
the applications of which has been shown in Chapters 2 and 3. To further elucidate the 
secretory mechanisms and predict genomic targets for improving recombinant protein 
production, herein I introduce the construction of a proteome-constrained genome-scale 
secretory model (pcSecYeast). In pcSecYeast, the protein secretory pathway was elaborated 
by adding a series of relevant metabolic reactions, including reactions for the generation of 
precursors from the central carbon metabolism, e.g. GPI and glycans, and the central 
reactions within the secretory pathway, e.g. protein translocation, glycosylation, folding, 
ERAD and sorting (Fig. 4-1), conceptually similar with the earlier published metabolic 
models for E. coli (83) and S. cerevisiae (84). Therefore, the model can simulate the whole 
process, including nascent polypeptide formation, protein maturation and protein transport to 
various destinations. To our knowledge, it is the first genome-scale metabolic model to 
comprehensively describe the protein synthesis and secretion process in yeast. Overall, 
pcSecYeast accounts for 1, 639 protein-coding genes and approximately 70% of the total 
proteome mass according to paxDb. 
As ribosome and protein synthesis demands substrates and energy from cellular metabolism, 
and the synthesized enzyme complexes are crucial for the catalysis of metabolic reactions, 
herein we introduced coupled constraints to correlate protein synthesis and cellular 
metabolism. Additionally, the synthesis of enzyme complexes also constrains the protein 
synthesis and secretion process, including ribosome synthesis and the synthesis of 
components involved in the secretory pathway. Moreover, in pcSecYeast, the flux of 
enzymatic reaction is constrained by the turnover number and the concentration of the 
enzyme, allowing the simulation of the minimum protein demand that maintains the 




Figure 4-1. Simplified schematic processes involved in the secretory pathway. The pathway 
includes protein translation, translocation, glycosylation, GPI transfer, ERAD and sorting processes. 
NG: N-glycosylation, OG: O-glycosylation, DSB: disulfide bond formation, GPI: 
glycosylphosphatidylinositol, ERAD: ER-associated degradation, LDSV: low-density secretory 
vesicles, HDSV: high-density secretory vesicles, ALP: alkaline phosphatase pathway, CPY: 
carboxypeptidase Y pathway. 
As mentioned previously, high-fidelity protein folding is a crucial pathway in the secretory 
machinery. Misfolded proteins, which can be caused by many internal or external factors, 
need to be refolded or delivered to the proteasome for degradation through ERAD pathway 
(20). Without proper handling, the accumulation of misfolded proteins can trigger cell 
disorder (85–87). Here, we simulated the process of vacuolar carboxypeptidase Y (CPY) 
production (88) to characterize the ER tolerance to the accumulation of misfolded proteins. 
In the model, the misfolding level of CPY is simulated by modifying the misfolding ratio. A 
misfolding ratio of 1 means that all CPY molecules are fully misfolded and cannot be targeted 
to the Golgi for further processing, as reported by Haynes et al. (89). The maximum growth 
reduction was used to characterize the cellular fitness cost when expressing CPY with 
different misfolding ratio. We found that there was ~1.9% maximum growth reduction when 
expressing 0.46 mg native CPY without misfolding (representing 0.1% of the total proteome, 
Fig. 4-2), which is comparable to a previous study that simulates the expression of the yellow 
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fluorescent protein (YFP) (90). The simulation showed that a higher misfolding ratio or a 
longer ER retention time led to a higher maximum growth reduction, i.e., a higher fitness 
cost. 
 
Figure 4-2. Reduction of simulated maximum specific growth rate (1/h) due to expression at 
certain level of CPY following different routes.  
Furthermore, we also investigated the correlations between CPY expression, misfolding and 
cell growth (Fig. 4-3). It is shown that when CPY was expressed at high levels, the high 
misfolding ratio would cause a steep decrease of cell growth (Fig. 4-3a). In addition, the 
misfolded proteins were prior to be degraded rather than accumulated (Fig. 4-3b and c). 
However, when the amount of misfolded proteins exceeded the degradation capacity, a steep 
increase of accumulation rate was observed (Fig. 4-3c). 
 
 
Figure 4-3. Simulation of physiological rates with varying CPY expression level and misfolding 
ratio. 
In addition to the characterization of the protein synthesis and secretion process, the model 
also can be used to identify the rate-limiting steps for improving recombinant protein 
production. Here, genomic target prediction was performed through flux scanning based on 
enforced objective function (FSEOF) (91), where the model was constrained with a stepwise 





Figure 4-4. Prediction of overexpression targets for improving α-amylase production. a Adapted 
FSEOF method used for target identification. FSEOF: Flux Scanning based on Enforced Objective 
Function. b Protein localization of the predicted overexpression targets. Yeast compartmentalized 
figure source: SwissBioPics.  
We used α-amylase as model recombinant protein and performed the target prediction. The 
predicted targets were divided into different groups based on their functions relevant to 
protein synthesis and secretion, and in each group the most promising targets were chosen 
based on their predicted values. In total, 17 targets were selected, including 14 secretory 
targets and 3 metabolic targets. The 14 secretory targets are involved in protein translocation, 
protein folding and sorting, and the 3 metabolic targets are related to N-glycan synthesis and 
amino acid synthesis (Fig. 4-4b). Next, we performed single-gene overexpression to validate 
if these targets are important for improving α-amylase production. Among these targets, 
overexpression of CWH41 (92), ERV29 (8), SEC16 (64) and PDI1 (8, 93) has already been 
reported to be useful for improving α-amylase production. The effects of remaining 13 targets 




Figure 4-5. Validation of overexpression targets for improving α-amylase production. Data 
shown are mean values ± standard errors of the means of biological triplicates. Statistical significance 
was determined by a two-tailed Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
It was indicated that the overexpression of MNS1, SEC65, ERV2, ERO1, SWA2 and CYS4 
significantly increased the α-amylase yield, separately. Among them, Mns1p is responsible 
for the removal of one mannose residue from a glycosylated protein. The multiple N-
glycosylation sites of α-amylase suggested the important role of Mns1p on its production. 
Sec65p is one out of six subunits of the signal recognition particle (SRP), which is involved 
in protein targeting to the ER (94). Overexpression of Sec65p is anticipated to increase the 
SRP dependent co-translational translocation, which would benefit α-amylase translocation 
from cytosol to the ER. Erv2p and Ero1p are involved in the protein folding process in the 
ER (65). Additionally, overexpression of Ero1p is proved to enhance disulfide-bonded human 
serum albumin (HSA) secretion in Kluyveromyces lactis (95) and single-chain T-cell 
receptors (scTCR) and single-chain antibodies (scFv) secretion in S. cerevisiae (96), 
suggesting it as a generic target for secretory protein production. Swa2p is involved in 
vesicular sorting, which is an important step for protein secretion. Cys4p is involved in 
cysteine synthesis. In the amino acid composition of α-amylase, the fraction of cysteine is 9-
fold higher than the average cysteine demand of yeast proteome (58), which demonstrates 
the importance of cysteine synthesis in α-amylase production. In total, for the identified 
targets in the secretory pathway, the accuracy was 9/14, while for the 3 metabolic targets, the 
accuracy was 1/3. The higher proportion and higher accuracy of the secretory targets probably 
indicates that the rate-limiting steps for recombinant protein production are more related to 










Protein synthesis and secretion is a vital process to maintain cell function. Here, we 
systematically characterize the protein synthesis and secretion process in Saccharomyces 
cerevisiae through integrative analysis of multi-omics data and genome-scale metabolic 
modeling. In Paper I and Paper II, through characterization of the recombinant protein 
production strains, we quantified the cellular resource reallocation in response to recombinant 
protein production and identified the underlying mechanisms in the protein secretory pathway 
for improving recombinant protein production, respectively. Surrounding the protein 
synthesis process, we also quantified the reserves in translational capacity and found that a 
major part of the translation capacity reserves is preferentially maintained for metabolic 
processes (Paper III). Moreover, we integrated the protein translation, protein post-
translational modifications, ERAD and sorting processes into a genome-scale metabolic 
model of yeast (Yeast8) to construct the pcSecYeast model, enabling simulation of the protein 
synthesis and secretion process and prediction of high-accuracy genomic targets for 
improving recombinant protein production (Paper IV). Our study also demonstrates the 
combination of multi-omics data analyses and metabolic modeling to dissect complex cellular 









6. Future perspectives 
6.1 Cofactor supply in protein synthesis and secretion 
The yeast S. cerevisiae is a popular cell factory that has been engineered to produce many 
kinds of chemicals and recombinant proteins. The central carbon metabolism is usually 
reshaped to meet the production demand of various chemicals (5, 97), herein we found that 
in response to improving recombinant protein production, cell metabolism was 
reprogrammed to provide more cytosolic NADPH and amino acids (Paper I). Energy and 
redox status, which are typically represented by relative levels of cofactor pairs such as 
ATP/ADP, NADPH/NADP+ and NADH/NAD+, are two key elements leading to the 
remodeling of metabolism (4). In energy metabolism, there is a trade-off between respiration 
and fermentation to balance the ATP yield and protein cost in response to dynamic 
environments (98). In this study, the decreased fermentation and the uncoupling between 
TCA cycle and oxidative phosphorylation indicated that the supply of cytosolic redox 
capacity prior to energy was critical for the metabolic reprogramming for protein production, 
which is in line with the severe oxidative stress caused by recombinant protein production 
(65). Therefore, the accumulation of glycerol in the protein production strains mainly 
contributed to the maintenance of redox potential, which is also found in previous studies (64, 
99). Interestingly, we did not observe any increase in the fraction of proteome allocated to 
the PPP, which is typically considered to be a crucial pathway for cytosolic NADPH supply. 
The overall decreased abundance of mitochondrial components potentially indicates a 
presumable decrease in the mitochondrial volume, which is also observed in a previous study 
(64). The oxidative phosphorylation process consumes redox power to generate energy and 
increases cellular oxidative stress, and this could lead to decreased mitochondrial components, 
considering the high oxidative stress in protein production strains (7, 65). Meanwhile, the 
increased enzyme usage on TCA cycle and amino acid biosynthesis showed metabolic 
homeostasis and revealed the reserved capacities maintained by metabolic pathways. 
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6.2 The regulatory network 
Cells have evolved global regulatory network to ensure that metabolic homeostasis is 
maintained. Learning how the regulation works enables a deep understanding of the cell 
systems and provides us novel insights which can be leveraged in synthetic biology and 
metabolic engineering studies. Phosphorylation is an important post-translational 
modification that is widely involved in signal transduction and regulation (100). In eukaryal 
cells, the two most important regulators of metabolism are AMP-activated kinase (AMPK) 
and target of rapamycin complex 1 (TORC1) (101), which regulate metabolism through 
phosphorylation of enzymes. In Paper I, by examining the phosphoproteomic abundance, 
we found that processes related to translation were highly regulated by phosphorylation in 
response to increased protein production. Further investigation showed that the amino acid 
starvation-induced Gcn2p-mediated signaling pathway is a central link between protein 
production and central carbon metabolism, which demonstrates the importance of 
phosphoproteome analysis since the abundance of the proteins involved in this pathway kept 
constant. Additionally, many other types of post-translational modifications, e.g. acylation 
and sumoylation, can alter protein function as well. Therefore, the combination of protein 
post-translational modification information with traditional omics data, e.g. proteome and 
transcriptome, can provide a more comprehensive understanding of cell status, which also 
calls for the development of high-throughput techniques for quantitative measurement of 
protein post-translational modifications. 
6.3 Novel insights into the secretory pathway 
Characterization of cell factories for recombinant protein production is a feasible approach 
for unraveling of the underlying mechanisms in the secretory pathway. Through modulating 
the recombinant protein yield (from zero to one and from one to hundreds), we successfully 
identified the metabolic reprogramming on the central carbon metabolism in response to 
recombinant protein production (Paper I) and the important role of post-translational 
modifications on protein production, especially the folding quality control system (Paper II). 
The combined results show that it is necessary to consider both the central metabolism, i.e. 
the supply of redox power, amino acids and energy, and the post-translational modifications, 
for improving recombinant protein production. In fact, there is also a link between these two 
strategies, namely balancing of redox power. As the oxidative stress caused by recombinant 
protein production is mainly due to the protein folding process and the degradation of 
misfolded proteins (65), the increased cytosolic NADPH supplied by TCA cycle also 
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highlights the impact of post-translational modifications on metabolic reprogramming. To 
date, efforts for improving protein production have primarily targeted the components of the 
secretory pathway, i.e. proteins involved in the folding pathway or the trafficking process (8, 
102–104). Our studies showed that the specific cofactor generation pathway and the specific 
signaling pathway are also promising alternatives for improving protein production. 
Protein folding process is often regarded as the rate-limiting step in the secretory pathway. 
Paper II indicates that, in addition to protein folding capacity, protein folding precision also 
can be modulated by cell engineering, and its improvement can lead to higher recombinant 
protein yield. As there are many human diseases caused by protein misfolding (23), including 
Alzheimer’s disease, Parkinson’s disease and type II diabetes. Further improving the protein 
folding precision may benefit the development of new drugs that are used for treatment of 
these protein misfolding diseases. 
In addition, the model pcSecYeast provides a novel platform for the elucidation of underlying 
mechanisms related to the secretory pathway (Paper IV). The simulation of the cellular 
response to protein misfolding revealed the causation of ER stress. At present, the model 
incorporates most fundamental processes in the secretory pathway, including protein 
translocation, N-glycosylation, protein folding and ER-associated degradation, further 
extension of the model to incorporate the unfolded protein response (UPS) and the Golgi 
processing could potentially increase the simulation accuracy. 
6.4 Protein translational reserves 
There is growing evidence in both E. coli (69, 105) and yeast (71) that cells maintain reserve 
capacities in protein translation process, trading off maximum exponential growth rate for 
the ability to respond quickly to changes in their growth environment. In Paper III we 
quantified for the first time the sizes of reserves of the transcriptome, proteome, translational 
capacity, without the confounding factor of a changing growth rate. Exposing cells to limited 
nitrogen resources revealed that yeast growing in typical laboratory conditions maintain an 
overall 50% reserve proteome, 75% reserve transcriptome, and 50% reserve translational 
capacity. Our analysis showed that a major part of these reserves is preferentially maintained 
for metabolic processes, highlighting the importance of a robust metabolism for cell growth 
and survival. Additionally, our data revealed that a global change in ksP is accommodated by 
adjusting the ribosomal protein stoichiometry, supporting the idea that a large diversity of 
ribosomes could be present in the cell and be responsible for large differences in gene-specific 
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ksP (82, 106). Indeed, several landmark studies have shown that ribosomes with or without a 
specific RP can translate functionally distinct sub-pools of mRNA (72–74), collectively 
known as the ribosome code (107, 108). We show here with high confidence that 17 RP 
subunits (22 RPs) are selectively upregulated under nitrogen-limited conditions and are 
associated with preferential translation for metabolic genes, expanding the ribosome code as 
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